Stroke trials in Oman

1 of 1 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

  Where

  Muscat

  Age

  12 years to 16 years

  People

  27 worldwide

  Run by

  Forma Therapeutics, Inc.

  See details and how to joinNCT05953584